-
Switching to Dolutegravir/Lamivudine Two-Drug Regimen: Durability and Virologic Outcomes by Age, Sex, and Race in Routine US Clinical Care
16 Apr 2024 07:27 GMT
… Medical, ViiV Healthcare, Brentford, UK; 5Department of Medicine, AIDS Healthcare … Two-drug regimens (2DR) may address drug–drug interactions … prescription receipt and pharmacy pick-up, … pandemic on HIV healthcare service engagement, treatment adherence, and …
-
Tumor-Infiltrating Lymphocyte Therapy Advances Into Melanoma
19 Apr 2024 17:28 GMT
… physicians, the medical oncologist, the … Biosciences, Inc; Aduro Biotech; Akeso, Inc; Amgen; … Pharmaceuticals, Inc; lncyte; Iovance Biotherapeutics, Inc; Merck; Merck Serono; Moderna, Inc; Merck Serono … a health care professional relative to diagnostic, treatment, …
-
FundaMental Pharma Names New CEO
11 Apr 2024 16:01 GMT
… molecule inhibitors for the treatment of a range of … in biotech leadership, Beher spent 14 years in pharmaceutical drug discovery, … Amgen (USA), and Merck Serono (CH). Beher was educated at … a fully-fledged biotech to bring much needed medicines to patients“. …
-
FundaMental Pharma appoints Dr. Dirk Beher as Chief Executive Officer
11 Apr 2024 11:00 GMT
… Amgen (USA), and Merck Serono (CH). Dirk was educated at … biotech to bring much needed medicines to patients“. “Leading FundaMental Pharma … small molecule inhibitors for treatment of a range of … entirely new class of drugs that safely counteract glutamate …
-
2024 Canada Gairdner Awards Recognize World-Renowned Scientists for Transformative Contributions to Research Impacting Human Health
11 Apr 2024 04:01 GMT
… investigated as potential treatments for additional disorders, … Smith Professor of Medicinal Chemistry, Yusuf Hamied … further vaccine introductions; on nutritional and pharmacological interventions … Department of Biotechnology’s Translational Health Science and …
-
TROP-2 Inhibitors Market to Boost by 2034, Predicts DelveInsight | Key Companies to Look Out - Daiichi Sankyo, AstraZeneca, Kelun Biotech, Merck, DualityBio, BioNTech, BiOneCure Therapeutics
09 Apr 2024 17:00 GMT
… TROP-2 Inhibitors Treatment Drugs TROP-2 Inhibitors … , AstraZeneca, Kelun Biotech, Merck, DualityBio, BioNTech … , Phio Pharmaceuticals, Atridia, Jiangsu HengRui Medicine, EMD Serono, Innovent Biologics … all the healthcare and pharma market research …
-
Caris Life Sciences Partner with Merck to Discover Novel Cancer Targets and Accelerate First-In-Class Antibody Drug Conjugate Development
04 Apr 2024 17:37 GMT
… operates its healthcare business as EMD Serono in the U … to discover novel, druggable targets that would be … development and commercialization of drug candidates emanating from these … special offers
from American Pharmaceutical Review – all delivered right …
-
Caris Life Sciences Announces Partnership with Merck KGaA, Darmstadt, Germany to Discover Novel Cancer Targets and Accelerate First-In-Class Antibody Drug Conjugate Development
04 Apr 2024 11:04 GMT
… TechBio company and precision medicine pioneer, today announced … operates its healthcare business as EMD Serono in the … company and precision medicine pioneer that is … medicine tools for early detection, diagnosis, monitoring, therapy selection and drug …
-
Multiple Sclerosis Drugs Market Projected to Reach $34.36 Bn by 2030, Flourishing at a CAGR of 3.60%
02 Apr 2024 07:25 GMT
… .
• Actelion Pharmaceuticals (Johnson & Johnson)
• EMD Serono (Merck KGaA) … advancements in biotechnology to target specific … healthcare infrastructure and resources. High treatment costs … essential MS medications, exacerbating healthcare inequities.
…
-
To advance women’s leadership, an effort ‘has to be purposeful,’ says EMD Serono exec
01 Apr 2024 12:26 GMT
The value of women in pharma and biotech leadership roles is no longer … Lebson
SVP, North America medical affairs, EMD Serono
Here, Lebson discusses the … Darmstadt, Germany, and won a Healthcare Businesswomen’s Association ACE Award …